Pittman B

Yale Depression Research Program, 100 York Street Suite 2J, New Haven, CT, 06511, USA.

5 papers · ORCID

ArticleKetamine

Lamotrigine is not associated with differential clinical outcomes in a real-world sample of patients with unipolar depression receiving ketamine or esketamine.

Santucci MC, Katz RB, Pittman B +2

Europe PMC2026
ArticleKetamine

Blood pressure changes during ketamine infusion for the treatment of depression.

Ansari M, Pittman B, Tylee DS +3

Europe PMC2024
ArticlePsilocybin

Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.

Sloshower J, Zeifman RJ, Guss J +5

Europe PMC2024
ArticlePsilocybin

Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.

Skosnik PD, Sloshower J, Safi-Aghdam H +4

Europe PMC2023
ArticlePsilocybin

Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial.

Sloshower J, Skosnik PD, Safi-Aghdam H +4

Europe PMC2023